Matthew Chau Hsien Ng
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
133
Citations
1,542
Est. group size
—
Recurring co-author estimate
Active years
25
Publishing since 2002
Matthew Chau Hsien Ng conducts clinical and translational cancer research, with a strong focus on gastrointestinal cancers such as gastric, gastroesophageal, and pancreatic tumors. The work spans early-phase clinical trials of new drugs (including antibody-drug conjugates and immunotherapies), molecular profiling of tumors, and blood-based biomarkers such as circulating tumor DNA. Several projects also apply computational and deep-learning methods to interpret tumor genetic data.
Publication activity has been steady with a notable increase in output around 2023-2024 compared to earlier years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Abstract P23: A deep-learning model for quantifying circulating tumour DNA from the density distribution of DNA-fragment lengths
Cancer Research · 2026
- A deep-learning model for quantifying circulating tumour DNA from the density distribution of DNA-fragment lengths
Nature Biomedical Engineering · 2025
- Spatial profiling of patient-matched HER2 positive gastric cancer reveals resistance mechanisms to targeted therapy
Gut · 2025
- Clinical activity of EBC-129, a first-in class, anti N256-glycosylated CEACAM5 and CEACAM6 antibody-drug conjugate (ADC), in patients with pancreatic ductal adenocarcinoma (PDAC) in a phase 1 study.
Journal of Clinical Oncology · 2025
- Perioperative pembrolizumab (pembro) plus chemotherapy (chemo) for locally advanced gastric or gastroesophageal junction (G/GEJ) cancer: Asia versus non-Asia subgroup analysis of KEYNOTE-585.
Journal of Clinical Oncology · 2025
- Exploring High PT Experimental Charges Through the Lens of Phase Maps
Minerals · 2025
- The PRL3-zumab paradigm: A multicenter, single-dose-level phase 2 basket clinical trial design of an unconventional cancer immunotherapy
Cell Reports Medicine · 2025
- Exploring High PT Experimental Charges Through the Lens of Phase Maps
Preprints.org · 2025
- 89O INSPIRE study: Innovating access to novel therapies through standardized prospective integration of response evaluations
ESMO Open · 2025
- 93O Perspectives from a 3-year review of expanded molecular profiling and tumor board-integrated clinical trial matching from a tertiary cancer centre in Singapore
ESMO Open · 2025
- 99P Pre-analytical barriers to successful molecular profiling
ESMO Open · 2025
- Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
UNC Libraries · 2025
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer
ESMO Open · 2024
- Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases
Gastroenterology · 2024
- Phase I PIANO trial—PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomes
ESMO Open · 2024
- Journal of Clinical Oncology×14
- Annals of Oncology×9
- ESMO Open×7
- bioRxiv (Cold Spring Harbor Laboratory)×5
- Asia-Pacific Journal of Clinical Oncology×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile